Sacubitril-valsartan versus enalapril for acute decompensated heart failure: a cost-effectiveness analysis
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Sacubitril-valsartan versus enalapril for acute decompensated heart failure: a cost-effectiveness analysis
Authors
Keywords
-
Journal
European Journal of Preventive Cardiology
Volume -, Issue -, Pages 204748731987895
Publisher
SAGE Publications
Online
2019-10-04
DOI
10.1177/2047487319878953
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mortality and Readmission Following Hospitalisation for Heart Failure in Australia: A Systematic Review and Meta-Analysis
- (2018) Mohammed S. Al-Omary et al. Heart Lung and Circulation
- Associations With and Prognostic and Discriminatory Role of N-Terminal Pro–B-Type Natriuretic Peptide in Heart Failure With Preserved Versus Mid-range Versus Reduced Ejection Fraction
- (2018) Gianluigi Savarese et al. JOURNAL OF CARDIAC FAILURE
- When more is less and less is more: Is there an additional value of NT-proBNP in risk stratification in heart failure?
- (2018) Petar M Seferović et al. European Journal of Preventive Cardiology
- National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand: Guidelines for the Prevention, Detection, and Management of Heart Failure in Australia 2018
- (2018) John J. Atherton et al. Heart Lung and Circulation
- A comparison of the prognostic value of BNP versus NT-proBNP after hospitalisation for heart failure
- (2018) G. C. M. Linssen et al. Netherlands Heart Journal
- Angiotensin–Neprilysin Inhibition in Acute Decompensated Heart Failure
- (2018) Eric J. Velazquez et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cost-effectiveness of sacubitril/valsartan in the treatment of heart failure with reduced ejection fraction
- (2017) John J V McMurray et al. HEART
- Outcomes of de novo and acute decompensated heart failure patients according to ejection fraction
- (2017) Ki Hong Choi et al. HEART
- Cost-Effectiveness Analysis of Natriuretic Peptide Testing and Specialist Management in Patients with Suspected Acute Heart Failure
- (2017) Edward A. Griffin et al. VALUE IN HEALTH
- IMPROV-ED study: outcomes after discharge for an episode of acute-decompensated heart failure and comparison between patients discharged from the emergency department and hospital wards
- (2016) Òscar Miró et al. Clinical Research in Cardiology
- Cost-Effectiveness of Sacubitril/Valsartan (Formerly LCZ696) in Chronic Heart Failure Patients with Reduced Ejection Fraction - An Analysis for Switzerland
- (2016) Z Ademi et al. VALUE IN HEALTH
- Changes in N-terminal pro-B-type natriuretic peptide levels and outcomes in heart failure with preserved ejection fraction: an analysis of the I-Preserve study
- (2015) Pardeep S. Jhund et al. EUROPEAN JOURNAL OF HEART FAILURE
- Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure
- (2014) John J.V. McMurray et al. NEW ENGLAND JOURNAL OF MEDICINE
- State-Transition Modeling: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-3
- (2012) Uwe Siebert et al. VALUE IN HEALTH
- Development of an economic model to assess the cost-effectiveness of hawthorn extract as an adjunct treatment for heart failure in Australia
- (2012) Emily Ford et al. BMJ Open
- Admission, Discharge, or Change in B-Type Natriuretic Peptide and Long-Term Outcomes
- (2011) Robb D. Kociol et al. Circulation-Heart Failure
- Diagnostic and Prognostic Significance of Plasma N-Terminal-Pro-Brain Natriuretic Peptide in Decompensated Heart Failure with Preserved Ejection Fraction
- (2008) Biju Paul et al. Heart Lung and Circulation
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now